Daniel P. Neumann is a Geneticist based in Adelaide, South Australia. He works with people and families who are dealing with rare genetic conditions, where answers can be hard to find and the next steps are not always clear.
His work focuses on Mucopolysaccharidosis Type 3 (MPS III), also called Sanfilippo Syndrome. This condition affects how the body breaks down certain materials in the body. Over time, it can impact development and everyday functioning. For many families, learning about MPS III comes with a lot of questions, and the emotional load can be heavy.
In a genetics role like this, the goal is usually practical. That means helping explain what the genetic result means in plain language, and what it can (and can’t) tell you. It also means supporting people to make sense of options, referrals, and follow-up care. At times, that can involve working closely with other clinicians to coordinate a care plan.
Genetics isn’t only about naming a condition. It’s also about understanding risk for other family members. Even when results are clear, the impact on family planning and long-term planning can be complicated. Daniel’s approach is calm and grounded, with an emphasis on clear communication and family support.
People who seek genetic help for conditions like MPS III can be at different points in their journey. Some are looking for a diagnosis after symptoms have been present for a while. Others may already have a diagnosis and want help interpreting genetic testing, or they need guidance for next steps. Many cases involve kids, carers, and parents working through big changes together.
Daniel’s location in Adelaide makes it easier for local families in South Australia to access genetics care. In many cases, appointments also link in with the wider local health system, depending on what support is needed most.
While the details of specific training and publications aren’t listed here, the focus remains on genetic understanding and helping families move forward with confidence. Rare disease work often involves staying up to date with what’s changing in genetics, and making sure families get the most relevant information for their situation.
Clinical trials can be part of the wider picture for some rare conditions. Whether a trial is relevant depends on a person’s diagnosis and individual circumstances, so any discussion around options usually comes down to careful, case-by-case checks.